UNC Health

     Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies

• Minimum Personal Protective Equipment Requirements for Hazardous Drug Activities Performed Outside of the Pharmacy
• Minimum Personal Protective Equipment Requirements for Hazardous Drug Activities Performed Inside of the Pharmacy

     System Formulary Restriction:

     Use of sacituzumab govitecan injection is restricted to patients in outpatient encounters or clinic use only (ie, no inpatient use)

     Orders must be signed by a Hematology/Oncology Attending Physician

     Use of sacituzumab govitecan injection is restricted to patients who meet the following criteria:

•      Patients who have received at least 2 standard treatment regimens

Med Center
     UNC Medical Center Formulary Restrictions

• Lexicomp
• Micromedex
• UpToDate
• FDA Daily Med